Terms: = Thyroid cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568
96 results:
1.
Li F; Wu Y; Shi Y; Liu X; Xie Y; Liu S
Acta Biochim Biophys Sin (Shanghai); 2024 Mar; 56(3):462-473. PubMed ID: 38379418
[TBL] [Abstract] [Full Text] [Related]
2. IL-17 A correlates with disease progression in papillary thyroid carcinoma.
Banerjee S; Nahar U; Dahiya D; Gupta R; Mukherjee S; Sachdeva N; Sood A; Dey P; Radotra B; Bhansali A
Diagn Pathol; 2023 Aug; 18(1):93. PubMed ID: 37563607
[TBL] [Abstract] [Full Text] [Related]
3. PTPRC promoted CD8+ T cell mediated tumor immunity and drug sensitivity in breast cancer: based on pan-cancer analysis and artificial intelligence modeling of immunogenic cell death-based drug sensitivity stratification.
Li P; Wang W; Wang S; Cao G; Pan T; Huang Y; Wan H; Zhang W; Huang Y; Jin H; Wang Z
Front Immunol; 2023; 14():1145481. PubMed ID: 37388747
[TBL] [Abstract] [Full Text] [Related]
4. Characteristics of immune response profile in patients with immediate allergic and autoimmune urticarial reactions induced by SARS-CoV-2 vaccines.
Wang CW; Chen CB; Lu CW; Chen WT; Hui RC; Chiu TM; Chi MH; Lin JC; Huang YH; Chang YC; Wu J; Chen KY; Lin YY; Ger TY; Lin JY; Tsai WT; Pan YJ; Chung WH
J Autoimmun; 2023 Jul; 138():103054. PubMed ID: 37245259
[TBL] [Abstract] [Full Text] [Related]
5. The Predicting Role of Serum TSGF and sil-2R for the Lymph Node Metastasis of Papillary thyroid Carcinoma.
Xu X; Wang W; Sun T; Tian B; Du L; Jing J
Dis Markers; 2022; 2022():3730679. PubMed ID: 36092957
[TBL] [Abstract] [Full Text] [Related]
6. The influence of thyroid hormone medication on intra-therapeutic half-life of
Happel C; Kranert WT; Bockisch B; Sabet A; Grünwald F; Groener D
Sci Rep; 2022 Aug; 12(1):13925. PubMed ID: 35978004
[TBL] [Abstract] [Full Text] [Related]
7. The continuum of care of anticancer treatment-induced hypothyroidism in patients with solid non-thyroid tumors: time for an intimate collaboration between oncologists and endocrinologists.
Deligiorgi MV; Trafalis DT
Expert Rev Clin Pharmacol; 2022 May; 15(5):531-549. PubMed ID: 35757870
[TBL] [Abstract] [Full Text] [Related]
8. Clinical Application Value of High-Frequency Ultrasound Combined with Detection of Serum High Mobility Group Box 1, Soluble il-2 Receptor, and Thyroglobulin Antibody in Diagnosing thyroid cancer.
Li N; Zhang J; Meng X; Yao W
J Healthc Eng; 2022; 2022():7851436. PubMed ID: 35392142
[TBL] [Abstract] [Full Text] [Related]
9. Immunomodulatory Effects of Omega-3 Fatty Acids in Patients with Differentiated thyroid cancer Before or After Radioiodine Ablation.
Amirkhani Z; Alavi M; Kalani M; Alavianmehr A; Farjadian S
Iran J Immunol; 2022 Mar; 19(1):7. PubMed ID: 35293348
[TBL] [Abstract] [Full Text] [Related]
10. BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary thyroid cancer.
Tao Y; Wang F; Shen X; Zhu G; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Zhao S; Wang Y; Xing M
J Clin Endocrinol Metab; 2021 Oct; 106(11):3228-3238. PubMed ID: 34273152
[TBL] [Abstract] [Full Text] [Related]
11. Relationship Between Serum Inflammatory Factor Levels and Differentiated thyroid Carcinoma.
Zhang X; Li S; Wang J; Liu F; Zhao Y
Technol Cancer Res Treat; 2021; 20():1533033821990055. PubMed ID: 33752541
[TBL] [Abstract] [Full Text] [Related]
12. Isovitexin potentiated the antitumor activity of cisplatin by inhibiting the glucose metabolism of lung cancer cells and reduced cisplatin-induced immunotoxicity in mice.
Chen RL; Wang Z; Huang P; Sun CH; Yu WY; Zhang HH; Yu CH; He JQ
Int Immunopharmacol; 2021 May; 94():107357. PubMed ID: 33715980
[TBL] [Abstract] [Full Text] [Related]
13. Intraoperative Nerve Monitoring in thyroidectomies for Malignancy: Does It Matter?
Leonard-Murali S; Ivanics T; Nasser H; Tang A; Singer MC
Am Surg; 2022 Jun; 88(6):1187-1194. PubMed ID: 33522279
[TBL] [Abstract] [Full Text] [Related]
14. Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma.
Harvey RD; Carthon BC; Lewis C; Hossain MS; Zhang C; Chen Z; Harris WB; Alese OB; Shaib W; Bilen MA; Lawson DH; Wu C; Steuer CE; El-Rayes BF; Khuri FR; Lonial S; Waller EK; Ramalingam SS; Owonikoko TK
Br J Cancer; 2020 Oct; 123(8):1228-1234. PubMed ID: 32704173
[TBL] [Abstract] [Full Text] [Related]
15. Endoplasmic reticulum stress-induced exosomal miR-27a-3p promotes immune escape in breast cancer via regulating PD-L1 expression in macrophages.
Yao X; Tu Y; Xu Y; Guo Y; Yao F; Zhang X
J Cell Mol Med; 2020 Sep; 24(17):9560-9573. PubMed ID: 32672418
[TBL] [Abstract] [Full Text] [Related]
16. IL-10 Restores MHC Class I Expression and Interferes With Immunity in Papillary thyroid cancer With Hashimoto thyroiditis.
Lu ZW; Hu JQ; Liu WL; Wen D; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32348468
[TBL] [Abstract] [Full Text] [Related]
17. Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune-checkpoint inhibitors.
Kurimoto C; Inaba H; Ariyasu H; Iwakura H; Ueda Y; Uraki S; Takeshima K; Furukawa Y; Morita S; Yamamoto Y; Yamashita S; Katsuda M; Hayata A; Akamatsu H; Jinnin M; Hara I; Yamaue H; Akamizu T
Cancer Sci; 2020 May; 111(5):1468-1477. PubMed ID: 32086984
[TBL] [Abstract] [Full Text] [Related]
18. IL-9-producing CD8
Ding P; Zhu R; Cai B; Zhang J; Bu Q; Sun DW
Int J Biochem Cell Biol; 2019 Oct; 115():105576. PubMed ID: 31362059
[TBL] [Abstract] [Full Text] [Related]
19. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis.
Han LT; Hu JQ; Ma B; Wen D; Zhang TT; Lu ZW; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
Diagn Pathol; 2019 Jun; 14(1):52. PubMed ID: 31159823
[TBL] [Abstract] [Full Text] [Related]
20. Association of raised levels of IL-4 and anti-TPO with hyperprolactinemia.
Kalsi AK; Halder A; Jain M; Chaturvedi PK; Mathew M; Sharma JB
Am J Reprod Immunol; 2019 Mar; 81(3):e13085. PubMed ID: 30614113
[TBL] [Abstract] [Full Text] [Related]
[Next]
